Latest Rome process Stories
Xifaxan® 550 mg is the first-and-only nonsystemic antibiotic approved for the treatment of IBS-D in adults LAVAL, Quebec, May 27, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International,
-First in class treatment for IBS-D treats hallmark symptoms of IBS-D; abdominal pain and diarrhea DUBLIN, May 27, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) announced today that
Entera Health, Inc.
Effective Doctor-Patient Communication is Essential MILWAUKEE, March 30, 2015 /PRNewswire/ -- Successful relationships between healthcare providers and those affected by long-term
A novel method for distinguishing different types of bowel disease using the stool samples of patients has been created by a group of researchers in the UK.
Researchers have identified a new form of irritable bowel syndrome (IBS) that occurs after an acute bout of diverticulitis, when parts of the intestine become inflamed or infected, causing patients significant pain.
Avail is conducting a Phase 2, randomized clinical study to evaluate the efficacy and safety of a new drug in female Subjects with diarrhea-predominant
The IBS Miracle is the newly updated irritable bowel syndrome diet plan designed by James Walden that claims to help people treat irritable bowel syndrome permanently.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.